Cibus, Inc. Files 8-K: Other Event Reported

TL;DR

Cibus filed an 8-K for an 'Other Event' - details TBD.

AI Summary

Cibus, Inc. filed an 8-K on September 17, 2024, reporting an "Other Event." The filing does not contain specific details about the event, its nature, or any associated financial implications. The company was formerly known as Calyxt, Inc. and is incorporated in Delaware.

Why It Matters

This filing indicates a significant event has occurred for Cibus, Inc., but the lack of detail requires further investigation to understand its potential impact on the company and its stakeholders.

Risk Assessment

Risk Level: medium — The filing is an 8-K for an 'Other Event' without specific details, creating uncertainty about the nature and impact of the reported event.

Key Players & Entities

• Cibus, Inc. (company) — Registrant
• Calyxt, Inc. (company) — Former company name
• Delaware (jurisdiction) — State of incorporation
• September 17, 2024 (date) — Date of report

FAQ

Key Financial Figures

• $0.0001 — which registered Class A Common Stock, $0.0001 par value per share CBUS The NASDAQ
• $10 — ee paid by farmers for the Bt traits is $10-$20 per acre, with aggregate trait fees
• $20 — aid by farmers for the Bt traits is $10-$20 per acre, with aggregate trait fees est
• $2.6 billion — e trait fees estimated at approximately $2.6 billion in corn, $0.7 billion in cotton, and $0
• $0.7 billion — at approximately $2.6 billion in corn, $0.7 billion in cotton, and $0.5 billion in soy. At
• $0.5 billion — on in corn, $0.7 billion in cotton, and $0.5 billion in soy. At this price, it is estimated
• $4.0 billion — ed by AgBioInvestor to be approximately $4.0 billion. It is further estimated by AgBioInvest
• $3.5 billion — trait fees estimated to be greater than $3.5 billion. Cibus believes that novel traits or
• $115.0 million — s approximately 16.5 years at a cost of $115.0 million. Conventional breeding techniques, on t
• $80 million — omer Accessible Acres and approximately $80 million in potential initial customer royalties
• $5 — a potential trait fee of approximately $5 per acre. For our PSR trait, four edite
• $100 million — lion customer Accessible Acres and over $100 million in potential initial customer royalties
• $40 — a potential trait fee of between $20 to $40 per acre in the specific geography. The
• $2 — Acre in this geography is approximately $2 to $3, yielding approximately $150 mill
• $3 — n this geography is approximately $2 to $3, yielding approximately $150 million in

Filing Documents

• d822939d8k.htm (8-K) — 90KB
• 0001193125-24-220705.txt ( ) — 219KB
• cbus-20240917.xsd (EX-101.SCH) — 3KB
• cbus-20240917_lab.xml (EX-101.LAB) — 17KB
• cbus-20240917_pre.xml (EX-101.PRE) — 11KB
• d822939d8k_htm.xml (XML) — 3KB

Forward Looking Statements

Forward Looking Statements This 8-K contains "forward-looking statements" within the meaning of applicable securities laws, including The Private Securities Litigation Reform Act of 1995. All statements, other than statements of present or historical fact included herein, including statements regarding Cibus' operational and financial performance, Cibus' strategy, future operations, prospects, and plans, including the anticipated regulatory environment are forward-looking statements. Forward-looking statements may be identified by words such as "anticipate," "believe," "intend," "expect," "plan," "scheduled," "could," "would" and "will," or the negative of these and similar expressions. These forward-looking statements are based on the current expectations and assumptions of Cibus' management about future events, which are based on currently available information. These forward-looking statements are subject to numerous risks and uncertainties, many of which are difficult to predict and beyond the control of Cibus. Cibus' actual results, level of activity, performance, or achievements could be materially different than those expressed, implied, or anticipated by forward-looking statements due to a variety of factors, including, but not limited to: Cibus' need for additional near-term funding to finance its activities and challenges in obtaining additional capital on acceptable terms, or at all; changes in expected or existing competition; challenges to Cibus' intellectual property protection and unexpected costs associated with defending intellectual property rights; increased or unanticipated time and resources required for Cibus' platform or trait product development efforts; Cibus' reliance on third parties in connection with its development activities; challenges associated with Cibus' ability to effectively license its productivity traits and sustainable ingredient products; the risk that farmers do not recognize the value in germplasm containing Cibus' tra

View Full Filing

View this 8-K filing on SEC EDGAR